Did Steve Cohen sell Aptevo Therapeutics stock?

Common questions

Did Steve Cohen sell Aptevo Therapeutics stock?

Yes. Steve Cohen disclosed 1 sale of Aptevo Therapeutics (APVO) stock on Jun 24, 2019, in STOCK Act reports. Added together, the disclosed ranges come to $471.

How big were Steve Cohen's Aptevo Therapeutics trades?

STOCK Act reports give a range for each trade, such as $471-$471, never an exact amount. Added together, the disclosed ranges come to $471.

Did Steve Cohen make these Aptevo Therapeutics trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Steve Cohen still own Aptevo Therapeutics stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Steve Cohen report these trades?

The latest filing is dated Jul 3, 2019. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.